These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35779626)

  • 1. Naringenin: A potential flavonoid phytochemical for cancer therapy.
    Motallebi M; Bhia M; Rajani HF; Bhia I; Tabarraei H; Mohammadkhani N; Pereira-Silva M; Kasaii MS; Nouri-Majd S; Mueller AL; Veiga FJB; Paiva-Santos AC; Shakibaei M
    Life Sci; 2022 Sep; 305():120752. PubMed ID: 35779626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics.
    Elsori D; Pandey P; Ramniwas S; Kumar R; Lakhanpal S; Rab SO; Siddiqui S; Singh A; Saeed M; Khan F
    Front Pharmacol; 2024; 15():1406619. PubMed ID: 38957397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Updated Review Summarizing the Anticancer Potential of Naringenin.
    Sharma S; Mishra A; Ramniwas S; Pandey P
    Endocr Metab Immune Disord Drug Targets; 2024 Jul; ():. PubMed ID: 39005120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive overview of how to fade into succinate dehydrogenase dysregulation in cancer cells by naringenin-loaded chitosan nanoparticles.
    Ragab EM; Khamis AA; Gamal DME; Mohamed TM
    Genes Nutr; 2024 May; 19(1):10. PubMed ID: 38802732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrus flavanone naringenin enhances melanogenesis through the activation of Wnt/β-catenin signalling in mouse melanoma cells.
    Huang YC; Yang CH; Chiou YL
    Phytomedicine; 2011 Nov; 18(14):1244-9. PubMed ID: 21802267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways.
    Lim W; Park S; Bazer FW; Song G
    J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive and anti-inflammatory effect of Naringenin in different nociceptive and inflammatory mice models.
    Xue N; Wu X; Wu L; Li L; Wang F
    Life Sci; 2019 Jan; 217():148-154. PubMed ID: 30414428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent.
    Rauf A; Shariati MA; Imran M; Bashir K; Khan SA; Mitra S; Emran TB; Badalova K; Uddin MS; Mubarak MS; Aljohani ASM; Alhumaydhi FA; Derkho M; Korpayev S; Zengin G
    Environ Sci Pollut Res Int; 2022 May; 29(21):31025-31041. PubMed ID: 35119637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells.
    Yang J; Li Q; Zhou XD; Kolosov VP; Perelman JM
    Mol Cell Biochem; 2011 May; 351(1-2):29-40. PubMed ID: 21229383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the Mitochondrial BK
    Kicinska A; Kampa RP; Daniluk J; Sek A; Jarmuszkiewicz W; Szewczyk A; Bednarczyk P
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32630135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin and its Nano-formulations for Fatty Liver: Cellular Modes of Action and Clinical Perspective.
    Zobeiri M; Belwal T; Parvizi F; Naseri R; Farzaei MH; Nabavi SF; Sureda A; Nabavi SM
    Curr Pharm Biotechnol; 2018; 19(3):196-205. PubMed ID: 29766801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A narrative review on Naringin and Naringenin as a possible bioenhancer in various drug-delivery formulations.
    Ganesh P; Suresh V; Narasimhan MK; Sabarathinam S
    Ther Deliv; 2023 Dec; 14(12):763-774. PubMed ID: 38088094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on the protective effects of naringenin against natural and chemical toxic agents.
    Naraki K; Rezaee R; Karimi G
    Phytother Res; 2021 Aug; 35(8):4075-4091. PubMed ID: 33724584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression.
    Xu J; Guo Z; Yuan S; Li H
    Mol Cell Biochem; 2022 May; 477(5):1541-1553. PubMed ID: 35184257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Pharmacological and Analytical Aspects of Naringenin.
    Patel K; Singh GK; Patel DK
    Chin J Integr Med; 2018 Jul; 24(7):551-560. PubMed ID: 25501296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest.
    Ahamad MS; Siddiqui S; Jafri A; Ahmad S; Afzal M; Arshad M
    PLoS One; 2014; 9(10):e110003. PubMed ID: 25330158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of naringenin in liver diseases: Molecular mechanisms.
    Hernández-Aquino E; Muriel P
    World J Gastroenterol; 2018 Apr; 24(16):1679-1707. PubMed ID: 29713125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Therapeutic Potential of Naringenin (4',5,7-Trihydroxyflavonone): Experimental Evidence and Mechanisms.
    Arafah A; Rehman MU; Mir TM; Wali AF; Ali R; Qamar W; Khan R; Ahmad A; Aga SS; Alqahtani S; Almatroudi NM
    Plants (Basel); 2020 Dec; 9(12):. PubMed ID: 33339267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Therapeutic Potential of Naringenin: A Review of Clinical Trials.
    Salehi B; Fokou PVT; Sharifi-Rad M; Zucca P; Pezzani R; Martins N; Sharifi-Rad J
    Pharmaceuticals (Basel); 2019 Jan; 12(1):. PubMed ID: 30634637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.